Sort
17,054 grants matching “genome editing”
Gene Targeting Facility
$402,951Lino Tessarollo · Division Of Basic Sciences - Nci · ZIC · FY2019 · CA
Dynamics of Clathrin Coat Formation in Cells
$402,942Tomas Kirchhausen · Boston Children'S Hospital · R01 · FY2015 · GM
Development of a Molecular Toolbox for Pneumocystis
$402,860Alan George Smulian · University Of Cincinnati · R61 · FY2025 · AI
Sequencing Coordination and Data Analysis Core
$402,777Pengyuan Liu · University Of Arizona · P01 · FY2024 · HL
Hereditary Cancer Variants of Uncertain Significance in Stem Cells
$402,702Christopher D. Heinen · University Of Connecticut Sch Of Med/Dnt · R01 · FY2021 · CA
Genetic studies linking LSP1 function in T cells to Inflammatory Bowel Disease
$402,600Benjamin Joachim Schmiedel · La Jolla Institute For Immunology · R01 · FY2023 · DK
Exploring novel SRC-regulated pathways in IDH mutant intrahepatic cholangiocarcinoma
$402,600Sita Kugel · Fred Hutchinson Cancer Center · R01 · FY2025 · CA
Exploring novel SRC-regulated pathways in IDH mutant intrahepatic cholangiocarcinoma
$402,600Sita Kugel · Fred Hutchinson Cancer Research Center · R01 · FY2021 · CA
Chemically Assisted Electrotransfer of DNA
$402,500Fan Yuan · Duke University · R35 · FY2025 · GM
Permanent alteration of PCSK9 in vivo genome editing
$402,500Kiran Musunuru · University Of Pennsylvania · R01 · FY2018 · HL
Developing next generation synthetic nucleic acid analogous for sickle cell disease gene editing
$402,500Raman Bahal · University Of Connecticut Storrs · R01 · FY2022 · HL
Chemically Assisted Electrotransfer of DNA
$402,500Fan Yuan · Duke University · R35 · FY2023 · GM
Towards the Design of Programmable, Isoform-Selective Proteome Editing System
$402,500Pranam Chatterjee · Duke University · R35 · FY2024 · GM
Developing next generation synthetic nucleic acid analogous for sickle cell disease gene editing
$402,500Raman Bahal · University Of Connecticut Storrs · R01 · FY2024 · HL
Stem Cells Models of Familial Combined Hypolipidemia
$402,500Kiran Musunuru · University Of Pennsylvania · R01 · FY2017 · HL
Chemically Assisted Electrotransfer of DNA
$402,500Fan Yuan · Duke University · R35 · FY2022 · GM
Developing next generation synthetic nucleic acid analogous for sickle cell disease gene editing
$402,500Raman Bahal · University Of Connecticut Storrs · R01 · FY2023 · HL
Stem Cells Models of Familial Combined Hypolipidemia
$402,500Kiran Musunuru · University Of Pennsylvania · R01 · FY2018 · HL
Developing next generation synthetic nucleic acid analogous for sickle cell disease gene editing
$402,500Raman Bahal · University Of Connecticut Storrs · R01 · FY2021 · HL
Molecular Basis of Drosophila Homeotic Gene Regulation
$402,500Peter J. Harte · Case Western Reserve University · R01 · FY2020 · GM
Permanent alteration of PCSK9 in vivo genome editing
$402,500Kiran Musunuru · University Of Pennsylvania · R01 · FY2017 · HL
Chemically Assisted Electrotransfer of DNA
$402,500Fan Yuan · Duke University · R35 · FY2024 · GM
Gene Edited and Engineered Tumor Cell Therapeutics for Cancer
$402,467Khalid A Shah · Brigham And Women'S Hospital · R01 · FY2024 · NS
Advanced recombinase-based gene expression technology in mammalian cells
$402,445Wilson Wong · Boston University (Charles River Campus) · R01 · FY2021 · GM
The impact of chromosome 17p lesions on leukemogeneis and therapy response
$402,371Scott W Lowe · Sloan-Kettering Inst Can Research · R01 · FY2016 · CA